4.5 Article

Altered Repertoire Diversity and Disease-Associated Clonal Expansions Revealed by T Cell Receptor Immunosequencing in Ankylosing Spondylitis Patients

Journal

ARTHRITIS & RHEUMATOLOGY
Volume 72, Issue 8, Pages 1289-1302

Publisher

WILEY
DOI: 10.1002/art.41252

Keywords

-

Categories

Funding

  1. Australian Government
  2. NHMRC of Australia [1071822, 1159458, 1024879]
  3. Arthritis Queensland
  4. National Health and Medical Research Council of Australia [1159458, 1071822] Funding Source: NHMRC

Ask authors/readers for more resources

Objective Ankylosing spondylitis (AS) is a common spondyloarthropathy primarily affecting the axial skeleton and strongly associated withHLA-B*27carriage. Genetic evidence implicates both autoinflammatory processes and autoimmunity against anHLA-B*27-restricted autoantigen in immunopathology. In addition to articular symptoms, up to 70% ofASpatients present with concurrent bowel inflammation, suggesting that adverse interactions between a genetically primed host immune system and the gut microbiome contribute to the disease. Accordingly, this study aimed to characterize adaptive immune responses to antigenic stimuli inAS. Methods The peripheralCD4 andCD8 T cell receptor (TCR) repertoire was profiled inASpatients (n = 47) andHLA-B*27-matched healthy controls (n = 38). Repertoire diversity was estimated using the Normalized Shannon Diversity Entropy (NSDE) index, and univariate and multivariate statistical analyses were performed to characterizeAS-associated clonal signatures. Furthermore, T cell proliferation and cytokine production in response to immunogenic antigen exposure were investigated in vitro in peripheral blood mononuclear cells fromASpatients (n = 19) andHLA-B*27-matched healthy controls (n = 14). Results Based on theNSDEmeasure of sample diversity acrossCD4 andCD8 T cell repertoires,ASpatients showed increasedTCRdiversity compared to healthy controls (forCD4 T cells,P= 7.8 x 10(-6); forCD8 T cells,P= 9.3 x 10(-4)), which was attributed to a significant reduction in the magnitude of peripheral T cell expansions globally. Upon in vitro stimulation, fewer T cells fromASpatients than from healthy controls expressed interferon-gamma (forCD8 T cells,P= 0.03) and tumor necrosis factor (forCD4 T cells,P= 0.01; forCD8 T cells,P= 0.002). In addition, theCD8TCRsignature was altered inHLA-B*27+ASpatients compared to healthy controls, with significantly expanded Epstein-Barr virus-specific clonotypes (P= 0.03) and cytomegalovirus-specific clonotypes (P= 0.02).HLA-B*27+ AS patients also showed an increased incidence of public CD8 TCRs, representing identical clonotypes emerging in response to common antigen encounters, including homologous clonotypes matching those previously isolated from individuals with bacterial-induced reactive arthritis. Conclusion The dynamics of peripheral T cell responses in AS patients are altered, suggesting that differential antigen exposure and disrupted adaptive immunity are underlying features of the disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Tolerance induction by liposomes targeting a single CD8 epitope IGRP206-214 in a model of type 1 diabetes is impeded by co-targeting a CD4+ islet epitope

Irina Buckle, Jeniffer D. Loaiza Naranjo, Anne-Sophie Bergot, Vivian Zhang, Meghna Talekar, Raymond J. Steptoe, Ranjeny Thomas, Emma E. Hamilton-Williams

Summary: The study showed that liposome delivery of IGRP (206-214) and calcitriol can delay the progression of type 1 diabetes and inhibit further destruction by CD8(+) T cells.

IMMUNOLOGY AND CELL BIOLOGY (2022)

Article Cell Biology

Secreted NF-κB suppressive microbial metabolites modulate gut inflammation

Rabina Giri, Emily C. Hoedt, Shamsunnahar Khushi, Angela A. Salim, Anne-Sophie Bergot, Veronika Schreiber, Ranjeny Thomas, Michael A. McGuckin, Timothy H. Florin, Mark Morrison, Robert J. Capon, Paraic O. Cuiv, Jakob Begun

Summary: An emerging research suggests that certain strains of Clostridium bacteria can suppress immune-mediated NF-KB activation, which could potentially alleviate inflammatory bowel diseases. Using an ex vivo organoid-based approach, researchers have identified a strain that could alleviate colitis in a relevant pre-clinical animal model of inflammatory bowel diseases.

CELL REPORTS (2022)

Article Rheumatology

Heterogeneity of axial spondyloarthritis: genetics, sex and structural damage matter

Zhixiu Li, Sjef M. van der Linden, Muhammad Asim Khan, Heinz Baumberger, Hermine van Zandwijk, Mohammad Kazim Khan, Peter M. Villiger, Matthew A. Brown

Summary: The objective of this study is to assess heterogeneity in axial spondyloarthritis (axSpA) and its sources. The results suggest that women clinically diagnosed with axSpA but without radiographic sacroiliitis have distinct characteristics compared to men with non-radiographic axSpA.

RMD OPEN (2022)

Letter Genetics & Heredity

Re: Best et al., 'Unlocking the potential of the UK 100,000 Genomes Project - Lessons learned from analysis of the Congenital malformations caused by ciliopathies cohort'

Matthew A. Brown, Christopher Wigley, Susan Walker, Deborah Lancaster, Augusto Rendon, Richard Scott

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2022)

Article Pharmacology & Pharmacy

Immune tolerance therapies for autoimmune diseases: Shifting the goalpost to cure

Patrick Sharkey, Ranjeny Thomas

Summary: Autoimmune rheumatic diseases are serious conditions characterized by inflammatory response to antigens, and while there have been advances in treatment, long-term remission without medication is still rare. However, research on immunopathogenesis and response to treatment has revealed novel therapeutic opportunities and improved understanding of preclinical disease states.

CURRENT OPINION IN PHARMACOLOGY (2022)

Article Rheumatology

Recurrence of axial spondyloarthritis among first-degree relatives in a prospective 35-year-follow-up family study

Sjef M. van der Linden, Muhammad Asim Khan, Zhixiu Li, Heinz Baumberger, Hermine van Zandwijk, Mohammad Kazim Khan, Peter M. Villiger, Matthew A. Brown

Summary: The lifetime recurrence risk of axSpA is substantial for HLA-B27(+) FDRs, and disease severity and the gender of the proband's children are associated with the risk of developing axSpA.

RMD OPEN (2022)

Article Rheumatology

Why Do Some Patients Have Severe Sacroiliac Disease But No Syndesmophytes in Ankylosing Spondylitis ? Data From a Nested Case-Control Study

Lauren K. Ridley, Mark C. Hwang, John D. Reveille, Lianne S. Gensler, Mariko L. Ishimori, Matthew A. Brown, Mohammad H. Rahbar, Amirali Tahanan, Michael M. Ward, Michael H. Weisman, Thomas J. Learch

Summary: This study investigated a subgroup of patients with ankylosing spondylitis (AS) who had long-standing disease and fused sacroiliac (SI) joints and found that females and males with early symptom onset had less radiographic damage in the SI joints. All 23 patients without syndesmophytes were HLA-B27 positive.

JOURNAL OF RHEUMATOLOGY (2023)

Review Rheumatology

Global epidemiology of rheumatoid arthritis

Axel Finckh, Benoit Gilbert, Bridget Hodkinson, Sang-Cheol Bae, Ranjeny Thomas, Kevin D. Deane, Deshire Alpizar-Rodriguez, Kim Lauper

Summary: Rheumatoid arthritis is a systemic autoimmune disease that mainly affects joints. The prevalence of RA varies globally, with higher rates in industrialized countries possibly due to environmental and genetic factors. Understanding the natural history of RA and its risk factors in specific populations may lead to prevention strategies.

NATURE REVIEWS RHEUMATOLOGY (2022)

Article Rheumatology

T cell Repertoire Profiling and the Mechanism by which HLA-B27 Causes Ankylosing Spondylitis

Jose Garrido-Mesa, Matthew A. Brown

Summary: The expansion of a restricted pool of CD8 lymphocytes is commonly found in AS patients, but only in a small proportion of healthy HLA-B27 carriers. These findings strongly support the theory that AS is driven by the presentation of antigenic peptides to the adaptive immune system by HLA-B27.

CURRENT RHEUMATOLOGY REPORTS (2022)

Review Immunology

Antigen-specific immunotherapy to restore antigen-specific tolerance in Type 1 diabetes and Graves' disease

Aakansha Zala, Ranjeny Thomas

Summary: Type 1 diabetes and Graves' disease are chronic autoimmune conditions characterized by immune dysregulation. Novel immunotherapies have been developed to induce self-tolerance and potentially achieve long-term remission. This review focuses on antigen-specific immunotherapies, including protein-based, peptide-based, dendritic-cell-based, and nanoparticle-based therapies, and discusses the translation of these therapies into clinical practice.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2023)

Article Immunology

Genetically encoded Runx3 and CD4+intestinal epithelial lymphocyte deficiencies link SKG mouse and human predisposition to spondyloarthropathy

Zaied Ahmed Bhuyan, M. Arifur Rahman, Muralidhara Rao Maradana, Ahmed M. Mehdi, Anne-Sophie Bergot, Davide Simone, Marya El-Kurdi, Jose Garrido-Mesa, Cheng Bang Benjamin Cai, Amy J. Cameron, Aimee L. Hanson, Hendrik J. Nel, Tony Kenna, Paul Leo, Linda Rehaume, Matthew A. Brown, Francesco Ciccia, Ranjeny Thomas

Summary: Loss-of-function variants in RUNX3 are associated with ankylosing spondylitis (AS) and lead to immune dysregulation, intestinal dysbiosis, and inflammation. In AS, CD4-IEL cells and CD4+CD8+ T cells are decreased, while Treg cells are increased. TCR signaling dysfunction plays a role in the intestinal T-cell immunodeficiency observed in AS.

CLINICAL IMMUNOLOGY (2023)

Editorial Material Genetics & Heredity

Genotype by sex interactions in ankylosing spondylitis

Zhixiu Li, Allan F. F. McRae, Geng Wang, Jonathan J. J. Ellis, Jessica Whyte, Tony J. J. Kenna, Matthew A. A. Brown, David M. M. Evans

NATURE GENETICS (2023)

Review Rheumatology

EULAR study group on 'MHC-I-opathy': identifying disease-overarching mechanisms across disciplines and borders

Jonas J. W. Kuiper, Joerg C. Prinz, Efstratios Stratikos, Piotr Kusnierczyk, Akiko Arakawa, Sebastian Springer, Dillon Mintoff, Ivan Padjen, Russka Shumnalieva, Secil Vural, Ina Koetter, Marleen G. van de Sande, Ayse Boyvat, Joke H. de Boer, George Bertsias, Niek de Vries, Charlotte L. M. Krieckaert, Ines Leal, Natasa Vidovic Valentincic, Ilknur Tugal-Tutkun, Hanane el Khaldi Ahanach, Felicie Costantino, Simon Glatigny, Danijela Mrazovac Zimak, Fabian Loetscher, Floor G. Kerstens, Marija Bakula, Elsa Viera Sousa, Peter Boehm, Kees Bosman, Tony J. Kenna, Simon J. Powis, Maxime Breban, Ahmet Gul, John Bowes, Rik J. U. Lories, Johannes Nowatzky, Gerrit Jan Wolbink, Dennis G. McGonagle, Franktien Turkstra

Summary: The 'MHC-I-opathy' concept describes a group of inflammatory diseases with overlapping clinical manifestations and a strong genetic link to the MHC-I antigen presentation pathway. However, the understanding and treatment of these disorders is limited due to patient heterogeneity and lack of systematic investigation. Therefore, interdisciplinary collaboration is needed to decipher the underlying disease mechanisms.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Review Immunology

Modelling the tumor immune microenvironment for precision immunotherapy

Nathan J. Mackenzie, Clarissa Nicholls, Abby R. Templeton, Mahasha Pj Perera, Penny L. Jeffery, Kate Zimmermann, Arutha Kulasinghe, Tony J. Kenna, Ian Vela, Elizabeth D. Williams, Patrick B. Thomas

Summary: The complexity of the tumor microenvironment has a significant impact on anticancer treatment. Current treatments mainly target cancer cells and neglect the role of other cells in the tumor microenvironment. Advances in immuno-oncology and bioengineering provide potential opportunities to model and optimize treatments at the individual patient level.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2022)

No Data Available